Log in
NASDAQ:EKSO

Ekso Bionics Stock Forecast, Price & News

$4.69
-0.38 (-7.50 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.69
Now: $4.69
$5.19
50-Day Range
$4.37
MA: $5.37
$6.52
52-Week Range
$2.25
Now: $4.69
$11.78
Volume66,136 shs
Average Volume1.13 million shs
Market Capitalization$38.79 million
P/E RatioN/A
Dividend YieldN/A
Beta2.09
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Read More
Ekso Bionics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars


Industry, Sector and Symbol

Industry General industrial machinery,
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EKSO
Previous SymbolOTCMKTS:EKSOD
CUSIPN/A
Phone510-984-1761

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.92 million
Book Value$1.17 per share

Profitability

Net Income$-12,130,000.00
Net Margins-156.16%

Miscellaneous

Employees77
Market Cap$38.79 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$4.69
-0.38 (-7.50 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

How has Ekso Bionics' stock price been impacted by COVID-19?

Ekso Bionics' stock was trading at $0.2616 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EKSO shares have increased by 1,692.8% and is now trading at $4.69.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Ekso Bionics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Ekso Bionics
.

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Ekso Bionics
.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings Inc (NASDAQ:EKSO) posted its quarterly earnings data on Thursday, July, 30th. The company reported ($1.88) earnings per share for the quarter, missing the consensus estimate of ($0.56) by $1.32. The company had revenue of $2.26 million for the quarter, compared to the consensus estimate of $1.85 million. Ekso Bionics had a negative net margin of 156.16% and a negative return on equity of 275.25%.
View Ekso Bionics' earnings history
.

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Shares of Ekso Bionics reverse split on the morning of Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

What price target have analysts set for EKSO?

3 brokers have issued 1 year price objectives for Ekso Bionics' stock. Their forecasts range from $8.00 to $12.00. On average, they anticipate Ekso Bionics' share price to reach $9.67 in the next year. This suggests a possible upside of 106.1% from the stock's current price.
View analysts' price targets for Ekso Bionics
.

Are investors shorting Ekso Bionics?

Ekso Bionics saw a drop in short interest in August. As of August 31st, there was short interest totaling 240,100 shares, a drop of 24.8% from the August 15th total of 319,100 shares. Based on an average trading volume of 2,960,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 3.3% of the company's stock are short sold.
View Ekso Bionics' Short Interest
.

Who are some of Ekso Bionics' key competitors?

What other stocks do shareholders of Ekso Bionics own?

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the following people:
  • Mr. Steven A. Sherman, Exec. Chairman (Age 73)
  • Mr. Jack Peurach, Pres, CEO & Director (Age 53)
  • Mr. John F. Glenn, CFO & Sec. (Age 57)
  • Mr. William Shaw, Chief Commercial Officer (Age 45)
  • Ms. Foon Lim Chwee, Pres of APAC

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

Who are Ekso Bionics' major shareholders?

Ekso Bionics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Atom Investors LP (0.91%), WINTON GROUP Ltd (0.24%), Bank of Montreal Can (0.23%) and Strategic Wealth Designers (0.18%).
View institutional ownership trends for Ekso Bionics
.

Which institutional investors are buying Ekso Bionics stock?

EKSO stock was purchased by a variety of institutional investors in the last quarter, including Atom Investors LP, Bank of Montreal Can, Strategic Wealth Designers, and WINTON GROUP Ltd.
View insider buying and selling activity for Ekso Bionics
.

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $4.69.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $38.79 million and generates $13.92 million in revenue each year. The company earns $-12,130,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis. Ekso Bionics employs 77 workers across the globe.

What is Ekso Bionics' official website?

The official website for Ekso Bionics is www.eksobionics.com.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.